
Mira Pharmaceuticals
(NASDAQ) MIRA
Mira Pharmaceuticals Financials at a Glance
Market Cap
$40.02M
Revenue (TTM)
$0.00
Net Income (TTM)
-$9.81M
EPS (TTM)
-$1.44
P/E Ratio
-0.66
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.96
Volume
401
Open
$0.96
Price
$0.96
Volume
401
Open
$0.96
Previous Close
$0.96
Daily Range
$0.96 - $0.96
52-Week Range
$0.90 - $2.45
Estimated Earnings Date
Sep 2, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.96
Volume
401
Open
$0.96
Previous Close
$0.96
Daily Range
$0.96 - $0.96
52-Week Range
$0.90 - $2.45
Estimated Earnings Date
Sep 2, 2026
MIRA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mira Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Erez Aminov
Website
mirapharmaceuticals.comHeadquarters
Baltimore, MD 21205, US
MIRA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-589%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-1.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$40.02M
Shares Outstanding
42.02M
Volume
401
Avg. Volume
147.93K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$10.49M
EBITDA
-$10.44M
Operating Cash Flow
-$4.66M
Capital Expenditure
$0.00
Free Cash Flow
-$4.66M
Cash & ST Invst.
$6.35M
Total Debt
$0.00
Mira Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$40.02M
N/A
Market Cap/Employee
$20.01M
N/A
Employees
2
N/A
Net Income
-$1.15M
+35.5%
EBITDA
-$1.15M
+35.5%
Quarterly Fundamentals
Total Cash
$9.41M
+679.8%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.04%
N/A
Return on Invested Capital
-1.05%
N/A
Free Cash Flow
-$1.20M
+26.3%
Operating Cash Flow
-$1.20M
+26.3%